Lonza Group AG

Industry

  • Services
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Drug Discovery Technologies
  • Digital Health
    • Disease Management
  • Diversified
  • Contract Research Organization-CRO

Other Names/Subsidiaries

  • Algonomics NV
  • Capsugel S.A.
  • HansaBioMed Life Sciences OÜ
  • InterHealth Nutraceuticals
  • Lonza Group
  • MODA Technology
  • Micro-Macinazione S.A.
  • PharmaCell B.V.
  • Synaffix B.V.
  • Triangle Research Labs
  • Zelam
  • Zelam Holdings.
See more in Biomedtracker

Latest on Lonza Group AG

Pink Sheet

Potency Assay Issues Delayed US FDA Approval Of Mesoblast’s Ryoncil For Years

 
• By Sue Sutter

Mesoblast ’s graft-versus-host disease treatment Ryoncil (remestemcel-L-rknd) exemplifies how shortfalls in product characterization and potency assay development can lead to lengthy delays in approva

Scrip

Deal Watch: Oak Hill Picks Up Where Roche Left Off In Angelman Syndrome

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Oak Hill Licenses Roche’s Rugonersen,

Scrip

Epsilogen Hits Antibody Acquisition Trail With TigaTx Takeover

 
• By Kevin Grogan

Epsilogen has acquired TigaTx of the US to create what the UK biotech claims will be “the world’s leading pan-isotype cancer antibody company.” The deal, the financials for which have not been discl

Scrip

Deal Watch: Lilly Looks To Alchemab’s ‘Resilient’ Antibodies To Take On ALS

 
• By Joseph Haas and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With UK’s Alchemab On A